Subscribe to Newsletter

October 2014 Issue of The Ophthalmologist

Register to download
Register here to download any issue of The Ophthalmologist for FREE.
Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Business & Profession Professional Development

Equanimity About Equality

Why are most of the speakers at congresses – and the vast majority of industry leaders – men?

Subspecialties Basic & Translational Research

Can We Regrow Schlemm’s Canal?

| Roisin McGuigan

Transgenic mouse studies have revealed a signaling pathway that’s central to Schlemm’s canal formation

Subspecialties Retina

A Glut of Glucose? Gibberish!

| Mark Hillen

Statins may interfere with glucose metabolism, and their use might be damaging the diabetic eye. Or perhaps not...

Subspecialties Retina

My Retina, My Rules

| Roisin McGuigan

Ophthalmologists would change recommendations if treating themselves

Business & Profession Professional Development

GPs, Don’t Fear the Retina (or the Lens, or the Cornea…)

| Roisin McGuigan

Survey shows UK-based GPs lack confidence in their ability to diagnose ocular disease

Business & Profession Professional Development

This Month in Business

| Roisin McGuigan

Alimera and Allergan benefit from new FDA approvals, Allergan continues to battle Valeant, and Oculentis sues Lenstec over IOL patent infringement

Business & Profession Business and Innovation

The Top 5 Lessons from Ophthalmology Futures 2014

| Mark Hillen

The world’s top clinicians and captains of industry came together in London last month to discuss the future of ophthalmology. Here’s what we learned

Business & Profession Business and Innovation

The Innovation Awards 2014

| Mark Hillen

Showcasing the greatest ophthalmic advances of the year

Subspecialties Cornea / Ocular Surface

Understanding Corneal Stem Cells Through Stripes

| John West, J. Martin Collinson

Fusing the embryos of mice, where one contains a marker of its lineage, is a well-established technique in developmental biology research. The stripy corneas were still a surprise, though…

Business & Profession Retina

Should Steroids Be Your First Port of Call in the Pseudophakic Eye?

| José Cunha-Vaz

Anti-VEGF agents are effective in treating DME – but not always indefinitely. Steroids work – but accelerate cataract development.

Business & Profession Refractive

Is Better the Enemy of Good?

| Gerd Auffarth, Florian Kretz

New intraocular lenses offer extended depth of focus, but this can come at a cost: glares, halos and comets. Can these be designed away?

Subspecialties Retina

Benchmarking VMA/VMT

| Mark Hillen

What does analysis of the last five years of the literature on vitreomacular traction/ adhesion tell us about the priorities of the field and the major contributors to it?

Business & Profession Refractive

Managing Expectations

| Shafiq Rehma

Five tips to ensure patients’ expectations of vision following cataract surgery are grounded in reality.

Business & Profession Professional Development

How Much Statistical Expertise Does an Ophthalmologist Really Need?

| Adam Jacobs

Peer reviewers should insist that tricky statistical techniques are explained clearly to non-statisticians.

Subspecialties Professional Development

Tiny Pulses, Big Progress

| Mark Latina

Mark Latina recounts his story of the invention of selective laser trabeculoplasty (SLT).

Subspecialties Professional Development

The Tyranny of Distance

Sitting Down With… Charles McGhee, Director of the New Zealand National Eye Centre, University of Auckland, New Zealand.

Other issues of 2014


The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: